Article Sidebar
Published:
Feb 17, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Anti-inflammatory effect of clearing-away-heat-promoting-diuresis and Wen-yang herbs on inflammatory signaling pathways in acute gout
Abstract
Purpose: To investigate the regulatory effect of clearing away, heat-promoting diuresis and Wen yang herbs (CHPW) on acute gout IL-1β inflammatory signaling pathways in rats and cell lines.
Methods: Thirty Sprague-Dawley (SD) rats were randomly divided into five groups: saline (SA group, SA-sodium urate (SA-SU) group, Colchicine-SU (Col-SU) group, CPHW-SU group, and clearing away heat-promoting diuresis-SU (CHP-SU) group. The cell line RAW264.7 groups were RAW264.7-A, RAW264.7-B, RAW264.7-C and RAW264.7-D. For the above cell groups, enzyme-linked immunosorbent assay (ELISA) was used to measure the effects of drugs on macrophage proliferation, and levels of IL-1β and other inflammatory factors, while quantitative real-time polymerase chain reaction (qRT-PCR) was used to assay NALP3 mRNA expression. The protein expressions of p-IRAK4, IRAK4, p-P65, P65, NALP3, and caspase-1 were measured using Western blot assay.
Results: Compared with SA-SU group, CHPW reduced gout symptoms in the joint, and reduced levels of myeloperoxidase (MPO) and IL-1β (p < 0.05). Compared with the SA group, the relative expression of NALP3 increased significantly in the SA-SU group (p < 0.05). The relative expression of NALP3 in CHPW and CHP groups decreased significantly, relative to the SA-SU group (p < 0.05). However, the expressions of p-IRAK4, IRAK 4 and p65 was basically unchanged (p > 0.05). Protein expression levels of NALP3 and caspase-1 were higher in SA-SU group, but lower in CHPW and CHP groups (p < 0.05).
Conclusion: CHPW exerts a protective effect against acute gout by downregulating the IL-1β inflammatory signaling pathway and decreasing the expression levels of NALP3 and p-P65. Thus, CHPW has a potential for use as a new therapeutic agent for gout.
